The IPO Porto, a major cancer treatment center in Portugal, is implementing proton therapy, a new form of radiotherapy that targets tumors more precisely than traditional methods. This technique uses protons that release energy directly at the tumor site, minimizing damage to healthy tissue and reducing side effects and secondary cancers caused by conventional radiation. The upgrade aims to prevent the need for patients, especially children, to travel abroad for treatment to countries like Italy, Switzerland, or Spain. The project is part of a strategic plan to make the already largest radiology service in the Iberian Peninsula the largest in Europe, supported by an 80 million euro donation from the Amancio Ortega Foundation. Additional investments include seven state-of-the-art linear accelerators funded by the PRR (Portuguese Recovery and Resilience Program), with treatments expected to begin in 2029.
Bias read (Center): The article focuses on medical advancements and infrastructure improvements in healthcare, which are not inherently politically charged. There is no evident ideological framing, biased language, or emphasis on political actors or policies. The content is primarily technical and informative.






